Atlas Trials

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

Clinical trial NCT06944067 · RECRUITING

Trial details

NCT number
NCT06944067
Sponsor
National Human Genome Research Institute (NHGRI)
Status
RECRUITING
Study type
OBSERVATIONAL
Sickle Cell Disease
Start date
2025-06-24
Primary completion
2030-04-10
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.